Oric Pharmaceuticals (ORIC) Net Cash Flow (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Net Cash Flow came in at $10.7 million in Q1 2026, up 206.5% YoY from $3.5 million in Q1 2025, and up 368.24% on a QoQ basis from -$4.0 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Net Cash Flow (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Net Cash Flow data on file, last reported at $10.7 million in Q1 2026.
- Quarterly Net Cash Flow rose 206.5% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (up 200.51% YoY) and the FY2025 annual result came in at -$13.7 million, down 138.14% from the prior year.
- Net Cash Flow grew to $10.7 million in Q1 2026, from -$4.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $44.7 million in Q2 2023 to a low of -$113.4 million in Q1 2022.
- A 5-year average of -$10.0 million and a median of -$5.6 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2022 — Net Cash Flow slumped 540.04% — and 2024, when it surged 631.74%.
- Tracing ORIC's Net Cash Flow over 5 years: stood at $37.8 million in 2022, then plunged by 107.56% to -$2.9 million in 2023, then surged by 631.74% to $15.2 million in 2024, then slumped by 126.35% to -$4.0 million in 2025, then jumped by 368.24% to $10.7 million in 2026.
- The last three Net Cash Flow figures came in at $10.7 million (Q1 2026), -$4.0 million (Q4 2025), and -$26.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - | -18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.91 Mn |
| Jun 30, 2026 | -18.91 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Mar 31, 2026 | 10.73 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Dec 31, 2025 | -4.00 Mn |
| Sep 30, 2025 | -26.20 Mn |
| Sep 30, 2025 | -26.20 Mn |
| Jun 30, 2025 | 26.53 Mn |
| Jun 30, 2025 | 26.53 Mn |
| Mar 31, 2025 | -10.07 Mn |
| Mar 31, 2025 | -10.07 Mn |
| Dec 31, 2024 | 15.18 Mn |
| Dec 31, 2024 | 15.18 Mn |
| Sep 30, 2024 | -5.60 Mn |
| Sep 30, 2024 | -5.60 Mn |
| Jun 30, 2024 | -6.53 Mn |
| Jun 30, 2024 | -6.53 Mn |
| Mar 31, 2024 | 32.98 Mn |
| Mar 31, 2024 | 32.98 Mn |